杭州赛基生物科技股份有限公司-是一家专注于生命科学研究与临床应用领域，以新型流式细胞免疫平台为重心的高科技公司

产品及
解决方案

了解我们如何更好地
为客户创造价值

Fluorescent Antibody

Certified Multiple Antibody Kits

customized mutiple antibody kit

Purified Antibody

sCD25/sCD40L/sCD130/sTREM-1 Multiplex Detection Kit

Immunoglobulin G Subclass Detection Kit

TGF-α/TGF-β1/CXCL12/VEGF/GM-CSF/G-CSF Multiplex Detection Kit

RANTES(CCL5)/MIG(CXCL9)/MCP-1(CCL2)/IP-10(CXCL10) Multiplex Detection Kit

新闻速递

关注我们的最新动态

Predicting Immunotherapy Efficacy with a Single Tube of Blood | Zhao Haitao's Team Latest Review: First Systematic Summary of the Clinical Application Value of PD-1⁺ T Cells in Solid Tumors

Zhao Haitao’s team at PUMCH published a landmark review in *International Immunopharmacology*, systematically summarizing the clinical value of peripheral blood PD-1⁺ T cells as a liquid biopsy biomarker for solid tumors.

5days ago

0

0

589

Literature Review | Methodological Validation and Clinical Value of Cellgenebio Flow Fluorescence Technology in AD Blood Detection

Alzheimer’s blood biomarker detection is advancing clinically, with plasma P-tau217/181 now in major guidelines. Costly equipment limits widespread use, but Cellgenebio’s novel flow fluorescence kit—validated clinically—achieves AUC 0.904 for P-tau181 and >95% accuracy with P-tau181/Aβ42 ratio.

5days ago

0

0

582

CellGene Biotech Flow Cytometry Reagents Used in Published Plasma p-tau217 Alzheimer's Study

A CellGene Biotech flow cytometry-based CBA assay for plasma p-tau217 showed 100% specificity, 88.9% sensitivity, and 92.2% accuracy in distinguishing Alzheimer’s dementia from controls and non-AD dementia, with strong concordance to the ALZpath Simoa assay.

2months ago

0

0

5364

Conference Invitation | Sincerely invite you to participate in the 2023 National Clinical Flow Cytology Testing Conference and the 3rd National Flow Cytology Industry Conference and the 3rd Southern Clinical Flow Forum (Saiji booth number: A8)

The 2023 National Clinical Flow Cytology Testing Conference and the 3rd National Flow Cytology Indus

2years ago

0

0

57592

Predicting Immunotherapy Efficacy with a Single Tube of Blood | Zhao Haitao's Team Latest Review: First Systematic Summary of the Clinical Application Value of PD-1⁺ T Cells in Solid Tumors

关于我们

探索我们的医疗之旅

0571-89167281

marketing@cell-genebio.com

|

|

|

|

|

© Copyright 2024 Hangzhou Cellgene Biotechnology Co., Ltd

Friendly link:

Drug Safety Cooperation Alliance

Journal of Drug Epidemiology

National Health Commission

SDA

China Medicinal Biotech Association

China Medicinal Biotech Association

Powerby Feedback Follow Data

Back to Top